Healthcare

The RDTI is the Australian Government’s main program for encouraging R&D investment, working as a cash refund of a share of eligible R&D spending for smaller companies. As a general rule only R&D carried out in Australia qualifies. An Advance Overseas Finding is a …

Under the MOU, AlgoraeRx is appointed as Umedica’s exclusive importer, distributor and commercial partner in Australia across a portfolio of eight molecules. Umedica acts as the manufacturer and Marketing Authorisation Holder. The exclusivity applies specifically to Umedica-branded, or sponsored, products only.

Revenue was $4.6 million, up 17% from $3.9 million in Q1 FY26. EBITDA was $1.3 million, up 31% from $1.0 million, and the EBITDA margin was 28.5%, up 3.1 percentage points from 25.4%. EBIT was $1.0 million, up 31% from $0.8 million. NPAT rose …

Operating cash flow was $243K from customer receipts of $5.26 million, up 3.1% from $5.10 million in the June quarter and broadly consistent with $5.36 million in the prior corresponding period. Reported operating cash flow rose 71% from $142K in Q1 FY26. Excluding the …

Pro Medicus acquired Visage Imaging in January 2009, a transaction that transformed the business into a global provider of medical imaging solutions. The company describes its Visage 7 suite of products as the foundation of an ultra-fast, clinically rich and highly scalable platform that …

The Centers for Medicare & Medicaid Services released preliminary 2027 Clinical Laboratory Fee Schedule rates under the Protecting Access to Medicare Act. They propose US$1,026 for Cxbladder Monitor, a rise of about 35%, and US$1,058 for Cxbladder Triage, a rise of about 39%, from …

Audeara Ltd (ASX:AUA) is advancing a transformative commercial expansion strategy, establishing direct clinical distribution channels across North America and Australasia for its medical-grade personalised listening technology. The Brisbane-based medical technology developer, which specialises in tailoring audio output to individual hearing profiles, reported on its …